Unc Lineberger Comprehensive Cancer Center
Clinical trials sponsored by Unc Lineberger Comprehensive Cancer Center, explained in plain language.
-
New Three-Drug cocktail aims to beat aggressive leukemia
Disease control Not yet recruitingThis study tests a new combination of three drugs—revumenib, azacitidine, and venetoclax—in people newly diagnosed with a specific, hard-to-treat leukemia called KMT2A-rearranged AML. The goal is to see if this cocktail can help more patients achieve remission with fewer side eff…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, olomorasib and pembrolizumab, as a first treatment for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and a PD-L1 score between 1% and 49%. The main goal is to see how long patients live without t…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
CLL patients may get a break from daily pills
Disease control Not yet recruitingThis study looks at whether people with chronic lymphocytic leukemia (CLL) who have been in remission for at least two years can safely stop taking their BTK inhibitor medication. The goal is to see how long they stay cancer-free without treatment, and whether stopping improves t…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Weight-Loss drug may slow uterine tumors before surgery
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes and weight loss, can slow or stop the growth of early-stage endometrial cancer or its precursor (EIN) in women with obesity. Forty participants will receive either tirzepatide or no additional treatment for 4 weeks be…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New cream after heat treatment may help women with HIV beat HPV
Disease control Not yet recruitingThis study tests whether a self-applied cream (5-fluorouracil) after a heat procedure (thermal ablation) can clear HPV better than a placebo cream in 140 women with HIV in Kenya. Participants will use the cream every two weeks for 24 weeks and be followed for 48 weeks total. The …
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
At-Home HPV tests could save lives of women with HIV
Disease control Not yet recruitingThis study looks at whether giving women living with HIV the option to collect their own HPV test samples at home or in their community, with help from health workers, increases how many get screened for cervical cancer. About 17,700 women will take part across multiple clinics. …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can simpler diet tracking and coaching boost weight loss? new study aims to find out.
Disease control Not yet recruitingThis study tests four extra tools added to a 6-month mobile weight loss program for 580 adults with overweight or obesity. The tools include switching from detailed calorie counting to a simple traffic-light food system, a goal planning tool, extra personalized texts, and health …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail aims to shrink oral tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, XL-092 and pembrolizumab (Keytruda), given before surgery to people with a type of oral cancer that is HPV-negative and can be removed. The goal is to see if the drugs can shrink or eliminate the tumor before the operation. Abo…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
At-Home HPV kits could boost cervical cancer screening in rural areas
Diagnosis Not yet recruitingThis study tests whether community health workers can help women in rural North Carolina use at-home HPV self-collection kits to screen for cervical cancer. About 112 women aged 30-64 who haven't been screened recently will receive kits through local organizations. The goal is to…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Virtual support platform aims to boost emotional health in testicular cancer survivors
Symptom relief Not yet recruitingThis study tests whether a virtual support platform can improve emotional well-being in men who had testicular cancer in the last 5 years. 360 men in North Carolina will be split into two groups: one gets access to the support platform, the other gets educational materials only. …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New program aims to ease financial burden for cancer patients
Symptom relief Not yet recruitingThis study tests a simple screening tool to identify cancer patients struggling with medical costs. Those who screen positive will be connected to financial counseling and resources at their hospital. The goal is to make it easier for patients to afford their care and reduce fina…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Exercise during chemo: new study tests strength training for children with leukemia
Symptom relief Not yet recruitingThis study tests whether a 9-week strength training program using resistance bands and body weight exercises is practical for children aged 6-21 newly diagnosed with acute lymphoblastic leukemia or lymphoblastic lymphoma. The program combines at-home exercises with optional Zoom …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
AI tool tested to lighten Doctors' load in rare cancer reporting
Knowledge-focused Not yet recruitingThis study looks at whether an artificial intelligence tool can reduce the mental strain doctors feel when writing case reports about rare tumors. Ten physicians, medical students, or postdoctoral students will write clinical vignettes with and without AI help in a single two-hou…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New online toolkit aims to boost cancer screening in lynch syndrome families
Knowledge-focused Not yet recruitingThis study tests an online tool called 'Let's Talk' designed to help people with Lynch syndrome encourage their relatives to get screened for the condition. Lynch syndrome is a genetic disorder that raises cancer risk, and only about half of close relatives currently get tested. …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Video consent may boost understanding for pancreatic cancer surgery
Knowledge-focused Not yet recruitingThis study looks at whether showing patients a short educational video before they sign consent for Whipple surgery (a complex operation for pancreas cancer) helps them understand the procedure better and feel more satisfied. About 60 adults will be split into two groups: one get…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to boost cervical cancer screening for women with HIV
Knowledge-focused Not yet recruitingThis study looks at how to make cervical cancer screening easier for women with HIV, who are at higher risk for this cancer. Researchers will talk to patients and doctors to find out what gets in the way of screening and follow-up care. They will also explore using HPV self-testi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Morning or afternoon? new study tests if immunotherapy timing boosts cancer fight
Knowledge-focused Not yet recruitingThis study looks at whether getting immunotherapy infusions in the morning versus the afternoon changes outcomes for people with advanced lung cancer or head and neck cancer. About 238 participants will be randomly assigned to morning or afternoon infusions. Researchers will trac…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can a smartwatch help cancer patients during chemo and radiation?
Knowledge-focused Not yet recruitingThis study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploadi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Pharmacy FIT kits aim to boost colon cancer screening
Knowledge-focused Not yet recruitingThis study looks at whether offering a simple take-home colon cancer test (FIT kit) at local pharmacies can increase screening rates. About 1,500 patients and pharmacy staff will take part. The goal is to see if this approach is practical, affordable, and effective at catching ca…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC